Nektar Therapeutics
NKTR
#6194
Rank
โ‚น79.46 B
Marketcap
โ‚น3,906
Share price
-6.86%
Change (1 day)
240.65%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): -โ‚น688.07

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น713.76. In 2024 the company made an earnings per share (EPS) of -โ‚น793.47 an increase over its 2023 EPS that were of -โ‚น1,961.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น688.07-13.28%
2024-โ‚น793.47-59.54%
2023-โ‚น1,961-25.89%
2022-โ‚น2,646-31.12%
2021-โ‚น3,84214.86%
2020-โ‚น3,345-1.19%
2019-โ‚น3,385-163.96%
2018โ‚น5,293-725.4%
2017-โ‚น846.30-42.73%
2016-โ‚น1,47883.33%
2015-โ‚น806.0039.53%
2014-โ‚น577.64-69.29%
2013-โ‚น1,881-6.67%
2012-โ‚น2,015

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
โ‚น1,167-263.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น154.04-121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น680.07-195.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
โ‚น0.90-100.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น271.80-138.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
-โ‚น59.11-91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚น185.38-125.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
โ‚น934.91-230.98%๐Ÿ‡บ๐Ÿ‡ธ USA